Las Vegas Sands Corp.

▲ Bull Case

• ◆Singapore duopoly provides a structural EBITDA floor: MBS alone is worth ~$57/share at 13x duopoly EBITDA, implying buyers at $50.88 are acquiring the Singapore asset at a discount and receiving Macau recovery plus the MBS IR2 option for approximately $11/share combined — a deeply asymmetric entry.
• ◆MBS IR2 represents a $27/share embedded option currently priced near zero. The $8.0B expansion targets $1.5–2.5B in incremental EBITDA at >20% ROIC, and if delivered on schedule by January 2031, materially re-rates the entire enterprise toward the $89 SOTP full target.
• ◆Macau recovery thesis remains intact and unpriced: LVS Macao is at ~85–88% of 2019 GGR peak with management guiding to $700M/quarter. Full normalization would push consolidated EBITDA toward $6.5B+, compressing the current 8x forward multiple to well below mid-cycle fair value of 10–13x.

▼ Bear Case

• ◆China geopolitical binary risk is the dominant tail risk. A US-China policy action restricting travel to Macau — analogous to COVID-zero — could rapidly collapse Macau GGR, erase the recovery thesis, and compress the stock toward the $18 severe-case scenario (-64.6% total return).
• ◆MBS IR2 execution risk: An $8.0B multi-year construction project carries meaningful cost overrun and delay risk. A >$1.0B overrun compresses ROIC from >20% toward 15% and reduces the IR2 option value by $9–12/share; a major delay shifts the incremental EBITDA timeline beyond 2031.
• ◆Macau structural share erosion: If LVS mass market share falls below 22% driven by competition from SJM Heritage of Tomorrow or Galaxy, each 1pp of share lost represents $3–5/share of EBITDA multiple compression, undermining both the recovery timeline and the $700M/quarter management target.

“The central debate is whether LVS deserves a China-risk-discounted multiple (8–9x) or a Singapore-duopoly premium multiple (12–13x) on consolidated EBITDA. Bears argue the Macau concession binary, US-China geopolitical overhang, and IR2 construction uncertainty justify the current discount. Bulls counter that the Singapore floor alone is worth close to the current stock price, making Macau recovery and IR2 optionality essentially free. A secondary debate concerns MBS IR2 capital allocation — whether $8.0B of incremental construction debt at a ~2.3x leverage ratio represents disciplined ROIC-accretive expansion or an overleveraged bet on a single property. Management's credibility on the $1.5–2.5B incremental EBITDA target is unverified by transcript evidence given TRANSCRIPTS_UNAVAILABLE.”

• ◆Macau monthly GGR reaching MOP 22B+ sustained over multiple months — approaching 100% of 2019 peak
• ◆LVS Macao quarterly EBITDA hitting the $700M management target on Londoner renovation completion
• ◆MBS IR2 on-schedule construction milestone confirmations through 2026–2027
• ◆US-China trade/geopolitical de-escalation compressing the China risk premium embedded in the multiple
• ◆LVS share buybacks exceeding $1B/yr pace at current sub-$55 prices

• ◆US-China geopolitical event triggering Macau travel restrictions — binary, rapid-onset, COVID-zero precedent
• ◆MBS IR2 cost overrun >$1.0B reducing ROIC and compressing the $27/share option value by $9–12/share
• ◆Macau GGR stagnation below MOP 16B for 3+ months signaling structural rather than cyclical demand weakness
• ◆Macau mass market share loss below 22% from SJM or Galaxy competition eroding the recovery timeline
• ◆Net leverage rising above 3.0x EBITDA as IR2 construction debt accumulates while EBITDA recovery lags